Similarly, Jones et al. discovered a global dysregulation of LAG-3 expression on CD4+ and CD8+ T cells from RRMS patients due to reduced LAG-3 transcription, which induced enhanced T cell proliferation and persistence as well as lower expression of apoptosis markers and resistance to cell death. This evidence concerns the gene LAG3 and relapsing-remitting multiple sclerosis.